Abstract: The 9th World Congress of Biomechanics 2022 will be held at the Taipei International Convention Center (TICC) in Taiwan from July 10-14. magAssist will participate in this year's congress online. Experts attending the event are welcome to visit magAssist's exclusive booth for company and product information. Meanwhile, Tingting Wu, a scientist at magAssist, will be presenting on the topic "Development of the robust maglev MoyoAssist® Extra-VAD at the event.
The World Congress of Biomechanics, organized by the World Council of Biomechanics, is a prestigious international conference on biomechanics worldwide. Since its inaugural meeting in 1990 in La Jolla, California, USA, it has been held every four years in cities in America, Europe, Asia, and Oceania on a rotating basis. Each conference is attended by leading scientists from around the world.
This year, the Congress once again brings together the world's leading scientists, engineers and cross-disciplinary experts in biomechanics for medical innovation and research. This year's congress also pays tribute to the scientists, doctors, and engineers who have made outstanding contributions to the fight against the epidemic in laboratories, hospitals, and medical companies around the world. The congress will play an important role in the academic exchange in the field of biomechanics discipline in China, and will also promote the cooperation and development of related cross-cutting areas of biomedical engineering discipline in China.
The development and design of an artificial heart is the collaborative effort of multiple disciplines and medical-industrial integration. Within three years, magAssist completed the development of China's first extracorporeal ventricular assist device. Meanwhile, we are also proud to have gained many valuable experiences during the process.
At this year's congress, Tingting Wu, a scientist at magAssist, will give a presentation on the "Development of the robust maglev MoyoAssist® Extra-VAD", in which she will introduce the leapfrog development of magAssist since its establishment in 2017. Starting from heart failure, magAssist has developed its first extracorporeal ventricular assist device in China, MoyoAssist® Extra-VAD, which has already been applied in a wide range of clinical settings and saved many patients' lives. These testimonials will be presented to the attending experts at the event.
As a participant of this conference, we hope to enhance the communication and cooperation with the international biomechanics academic community, and play an active role in promoting the development of biomedical engineering discipline.